U.S. markets close in 30 minutes

Yunkang Group Limited (2325.HK)

HKSE - HKSE Delayed Price. Currency in HKD
11.980+0.080 (+0.67%)
At close: 04:08PM HKT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close11.900
Bid11.880 x N/A
Ask12.020 x N/A
Day's Range11.880 - 11.980
52 Week Range11.780 - 17.200
Avg. Volume190,252
Market Cap7.443B
Beta (5Y Monthly)N/A
PE Ratio (TTM)36.30
EPS (TTM)0.330
Earnings DateN/A
Forward Dividend & Yield0.31 (2.59%)
Ex-Dividend DateJul 04, 2023
1y Target Est16.11
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for 2325.HK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Yunkang Group Announces First Annual Results Since Listing

      Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325.HK), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing.